Crumly & Associates’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Other funds holding MDT
LMFP
FWIA
SRIM
DC
CAI
ETC
Crumly & Associates's MDT Position: Q2 2026 in Review
Crumly & Associates sold out of Medtronic (MDT) in Q2 2026, closing a stake of 8,934 shares — an estimated $774K sold.
Crumly & Associates first reported a position in MDT in Q1 2020 and held it in 23 quarters. The position peaked at $774K in Q1 2026. 606 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Crumly & Associates reported no remaining Medtronic position as of Q2 2026 after selling out during the quarter.
- Crumly & Associates sold 8,934 Medtronic shares in Q2 2026, an estimated $774K.
- Crumly & Associates first reported a position in Medtronic in Q1 2020 and held it in 23 quarters.
- Crumly & Associates's Medtronic position peaked at $774K in Q1 2026.
- 606 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Crumly & Associates's 13F filing for Q2 2026, filed 8 Jul 2026.